Wallace V. Crandall, MD

Wallace Crandall, MD, is Director of the Center for Pediatric and Adolescent Inflammatory Bowel Disease and Associate Medical Director for Quality Improvement at Nationwide Children’s Hospital and Professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Crandall is an expert in pediatric IBD and quality improvement. He has a large number of active research projects in IBD, and has published extensively on IBD and Quality Improvement. An active member of the Crohn’s and Colitis Foundation of America (CCFA), Dr. Crandall has served at both the regional and national levels of CCFA. He serves on the Executive Committee and as the Director of Quality for ImproveCareNow, a national pediatric IBD quality improvement collaborative. He is also Chair of the IBD Committee of NASPGHAN and Co-Chair of their Quality Improvement Task Force. Dr. Crandall has been listed repeatedly in “Best Doctors in America.”

Gender:

• Male

Languages Spoken:

• English

Research Center:

• Hospital-Based Research Faculty

Research Funding*:

• Crohn’s Disease Treatment Study, Anonymous
• Industry Sponsor, Anonymous

Medical School

• University of Utah
  Date Completed: 05/21/1994

Internship

• St Louis Children's Hospital
  Date Completed: 06/30/1995

Residency

• St Louis Children's Hospital
  Date Completed: 06/30/1997

Fellowship

• St Louis Children's Hospital
  Date Completed: 06/30/2000

Department:

• Pediatrics

Section:

• Gastroenterology/Nutrition

Speciality:

• Pediatric Gastroenterology
  

Date of Appointment at Nationwide Children’s Hospital:

• 09/12/2000

• Dotson J, Crandall W, Bout-Tabaku S. 2011. Exploring the differential diagnosis of joint complaints in pediatric patients with inflammatory bowel disease.  Curr Gastroenterol Rep. Vol. 13, no. 3. (June): 271-278.
• Hyams J, Lerer T, Mack D, Bousvaros A, Griffiths A, Rosh J, Otley A, Evans J, Stephens M, Kay M, Keljo D, Pfefferkorn M, Saeed S, Crandall W, Michail S, Kappelman M, Grossman A, Samson C, Sudel B, Oliva-Hemker M, Leleiko N, Markowitz J. 2011. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.  Am J Gastroenterol. Vol. 13, no. 3. (June): 981-987.
• Mackner L, Clough-Paabo E, Pajer K, Crandall W. 2011. Psychoneuroimmunologic factors in inflammatory bowel disease.  Inflamm Bowel Dis (Accepted). Vol. 17, no. 3. (March): 849-857.
• Hyams J, Walters T, Crandall W, Kugathasan S, Griffiths A, Blank M, Johanns J, Lang Y, Markowitz J, Cohen S, Witner H, Veereman-Wauters G, Ferry G, Baldassano R. 2011. Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension.  Curr Med Res Opin. Vol. 27, no. 3. (March): 651-662.
• Crandall W, Boyle B, colletti R, Margolis P, Kappelman M. 2011. Development of Process and Outcome Measures for Improvement-Lessons Learned in a Quality Improvement Collaborative for Pediatric Inflammatory Bowel Disease.  Inflamm Bowel Dis.
• XXXXXXX. 2011. C-Reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis.  Journal of Crohn's and Colitis.
• Kappelman M, Crandall W, Colletti R, Goudie A, Leibowitz I, Duffy L, Milov D, Kim S, Schoen B, Patel A, Grunow J, Larry E, Fairbrother G, Margolis P. 2011. Short Pediatric Crohn's Disease Activity Index for Quality Improvement and Observational Research.  Inflamm Bowel Dis. Vol. 17, no. 1. (January): 112-117.
• Dotson J, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint, J, Dienhart M, Jaggi P, Carvalho R. 2011. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with anti-tumor necrosis factor alpha therapy: A case series.  Inflamm Bowel Dis. Vol. 17, no. 1. (January): 56-61.
• Siegel CA, Siegel LS, Hyams JS, Kugathasan S, Markowitz J, Rosh JR, Leleiko N, Mack DR, Crandall W, Evans J, Keljo DJ, Otley AR, Oliva-Hemker M, Farrior S, Lanton CR, Wrobel IT, Wahbeh G, Quiros JA, Silber G, Bahar RJ, Sands BE, Dubinsky MC. 2011. A Real-time tool to display the predicted disease course and treatment response for children with Crohn's Disease.  Inflamm Bowel Dis. Vol. 17, no. 1. (January): 30-38.
• Sylvester F, Turner D, Draghi A 2nd, Uuosoe K, McLernon R, Koproske K, Mack D, Crandall W, Hyams J, Leleiko N, Griffiths A. 2010. Fecal Osteoprotegerin May Guide the Introduction of Second Line Therapy in Hospitalized Children with Ulcerative Colitis.  Inflamm Bowel Dis.
• Long M, Crandall W, Leibowitz I, Duffy L, Del Rosario F, Kim S, Integlia M, Berman J, Grunow J, Colletti R, Schoen B, Patel P, Baron H, Israel E, Russell G, Ali S, Herfarth H, Martin C, Kappelman M. 2010. The Prevalence and Epidemiology of Overweight and Obesity in Children with Inflammatory Bowel Disease.  Inflamm Bowel Dis.
• Boyle, Mackner L, Ross C, Moses J, Kumar S, Crandall W. 2010. A Single-Center Experience with Methotrexate after Thiopurine Therapy in Pediatric Crohn's Disease.  J Pediatr Gastroenterol Nutr. Vol. 51, no. 6. (December): 714-717.
• Kabakchiev B, Turner D, Hyams J, Mack D, Leleiko N, Crandall W, Markowitz J, Otley A, Xu W, Hu P, Griffiths A, Silverberg M. 2010. Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.  PLoS One. Vol. 5, no. 9. (September).
• Kappelman MD, Crandall WV et al. 2010. A Short Pediatric Crohn's Disease Activity Index for Quality Improvement and Observational Research.  Inflammatory Bowel Disease.
• Turner D, Leach S, Mack D, Uusoue K, McLernon R, Hyams J, Leleiko N, Walters T, Crandall W, Markowitz J, Otley A, Griffiths A, Day A. 2010. Fecal calprotectin, lactoferrin, M2-pyruvate kinase, and S100A12 in severe ulcerative colitis: a prospective multicenter comparison of predicting outcomes and monitoring response.  Gut. Vol. 9, no. 59. (September): 1207-1212.
• Crandall W, Kappelman MD, Colletti RB, Leibowitz I, Grunow JE, Ali S, Baron HI, Berman JH, Boyle B, Cohen S, DelRosario F, Denson LA, Duffy L, Integlia MJ, Kim SC, Milov D, Patel AS, Schoen BT, Walkiewicz D, Margolis P. 2010. ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network.  Inflamm Bowel Dis (Epub ahead of print).
• Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, Leleiko N, Markowitz J. 2010. Outcome Following Infliximab Therapy in Children with Ulcerative Colitis.  Am J Gastroenterol. Vol. 6, no. 105. (June): 1430-1436.
• Turner D, Mack D, Leleiko N, Walters TD, Uusoue K, Leach ST, Day AS, Crandall W, Silverberg M, Markowitz J, Otley AR, Keljo D, Mamula P, Kugathasan S, Hyams J, Griffiths AM. 2010. Severe Pediatric Ulcerative Colitis: A Prospective Multicenter Study of Outcomes and Predictors of Response.  Gastroenterology. Vol. 7, no. 138. (June): 2282-2291.
• Schaefer ME, Machan JT, Kawatu D, Langton CR, Markowitz J, Crandall W, Mack DR , Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo DJ, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Kappelman MD, Saeed SA, Hyams JS, Leleiko NS. 2010. Factors that Determine Risk for Surgery in Pediatric Patients with Crohn's Disease.  Clin Gastroenterol Hepatol (Epub ahead of print). Vol. 9, no. 8. (May): 789-794.
• Turner D, Kolho KL, Mack DR, Raivio T, Leleiko N, Crandall W, Markowitz J, Silverberg MS, Janne OA, Stempak J, Hyams J, Griffiths AM. 2010. Gluocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis.  Inflamm Bowel Dis. Vol. 16, no. 3. (March): 469-473.
• Dotson J, Hyams J, Markowitz J, Leleiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton DR, Crandall W. 2010. Extra-Intestinal Manifesations of Pediatric Inflammatory Bowel Disease and Their Relation to Disease Type and Severity.  J Pediatr Gastroenterol Nutr. Vol. 2, no. 51. (January): 140-145.
• Boyle B, Mackner L, Ross C, Moses J, Kumar S, Crandall W. 2010. A Single-Center Experience with Methotrexate after Thiopurine Therapy in Pediatric Crohn's Disease (Accepted).  J Pediatr Gastroenterol Nutr.
• Dotson J, Crandall W, Mousa H, Honegger JR, Denson L, Samson C, Cunningham D, Balint J, Dienhart M, Jaggi P, Carvalho R. 2010. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with anti-tumor necrosis factor alpha therapy: A case series.  Inflamm Bowel Dis (E-Pub Ahead of Print).
• Crandall WV. 2010. Managing Specific Problems. In Your Child with Inflammatory Bowel Disease. Edited by Oliva-Hemer M, Ziring D, Bousvaros A. Baltimore, MD: John Hopkins Press.
• Rosh JR, Lerer T, Markowitz J, Goli SR, Mamula P, Noe JD, Pfefferkorn MD, Kelleher KT, Griffiths AM, Kugathasan S, Keljo D, Oliva-Hemker M, Crandall WV, Carvalho, RS, Mack DR, Hyams JS. 2009. Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohn's Disease.  AM J Gastroenterol. Vol. 104, no. 12. (December): 3042-3049.
• Colletti RB, Baldassano RN, Milov DE, Margolis PA, Bousvaros A, Crandall WV, Crissinger KD, Damico MA, Day AS, Denson LA, Dubinsky M, Ebach DR, Hoffenberg EJ, Kader HA, Keljo DJ, Leibowitz IH, Mamula P, Pfefferkorn MD, Quireshi MA. 2009. PIBDNet, the Pediatric IBD Network for Research and Improvement. Variation in Care in Pediatric Crohn Disease.  J Pediatr Gastroenterol Nutr. Vol. 49, no. 3. (September): 297-303.
• Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J, Pfefferkorn M, Rosh J, Kay M, Crandall W, Keljo D, Otley AR, Kugathasan S, Carvalho R, Oliva-Hemker M, Langton C, Mamula P, Bousvaros A, Leleiko N, Griffiths AM. 2009. Pediatric IBD Collaborative Research Group. Appraisal of the Pediatric Ulcerative Colitis Activity Index.  Inflamm Bowel Dis. Vol. 15, no. 8. (August): 1218-1223.
• Crandall W, Hyams J, Kugathasan S, Griffiths A, Zrubek J, Olson A, Liu G, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano RN. 2009. Infliximab Therapy in Children with Concurrent Perianal Crohn's Disease: Observations from REACH.  J Pediatr Gastroenterol Nutr. Vol. 49, no. 2. (August): 183-190.
• Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Kugathasan S, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Mamula P, Kay M, Crandall W, Oliva-Hemker M, Keljo D, Leleiko N, Markowitz J. 2009. Long-term outcome of maintenance infliximab therapy in children with Crohn’s disease. The Pediatric Inflammatory Bowel Disease Collaborative Research Group.  Inflamm Bowel Dis. Vol. 15, no. 6. (June): 816-822.
• Markowitz J, Kugathasan S, Dubinsky M, Mei L, Crandall W, Leleiko N, Oliva-Hemker M, Rosh J, Evans J, Mack D, Otley A, Pfefferkorn M, Bahar R, Vasiliauskas E, Wahbeh G, Silber G, Quiros JA, Wrobel I, Nebel J, Landers C, Picornell Y, Targan S, Lerer T, Hya. 2009. Age of diagnosis influences serologic responses in children with Crohn’s disease: A possible clue to etiology?.  Inflamm Bowel Dis. Vol. 15, no. 5. (May): 714-719.
• Keljo DJ, Markowitz J, Langton C, Lerer T, Bousvaros A, Carvalho R, Crandall W, Evans J, Griffiths A, Kay M, Kugathasan S, Leleiko N, Mack D, Mamula P, Moyer MS, Oliva-Hemker M, Otley A, Pfefferkorn M, Rosh J, Hyams JS. 2009. Course and treatment of perianal disease in children newly diagnosed with Crohn’s disease. Pediatric Inflammatory Bowel Disease Collaborative Research Group.  Inflamm Bowel Dis. Vol. 15, no. 3. (March): 383-387.
• Pfefferkorn M, Burke G, Griffiths A, Markowitz J, Rosh J, Mack D, Otley A, Kugathasan S, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Temker M, Carvalho R, Crandall W, Keljo D, Walters TD, LeLeiko N, Hyams J. 2009. Growth Abnormalities Persist in Newly Diagnosed Children with Crohn Disease Despite Current Treatment Paradigms.  J Pediatr Gastroenterol Nutr. Vol. 48, no. 2. (February): 168-174.
• Russo JM, Crandall WV. 2009. Transition of Care. In The Changing World of Inflammatory Bowel Disease. Edited by Scherl and Dubinsky (eds). New Jersey: SLACK Incorporated.
• Thayu M, Leonard MB, Hyams JS, Crandall WV, Kugathasan S, Otley AR, Olson A, Johanns J, Marano CW, Heuschkel RB, Veereman-Wauters G, Griffiths AM, Baldassano RN. 2008. Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study.  Clin Gastroenterol Hepatol. Vol. 6, no. 12. (December): 1378-1384.
• Hommel KA, Denson LA, Crandall WV, Mackner LM. 2008. Behavorial Functioning and Treatment Adherence in Pediatric Inflammatory Bowel Disease: Review and Recommendations for Practice.  Gastroenterol Hepatol. Vol. 4, no. 11. (November): e785.
• Hommel KA, Mackner LM, Denson LA, Crandall WV. 2008. Treatment regimen adherence in pediatric gastroenterology.  J Pediatr Gastroenterol Nutr. Vol. 47, no. 5. (November): 526-543.
• Dubinsky MC, Kugathasan S, Mei L, Picornell Y, Nebel J, Wrobel I, Quiros A, Silber G, Wahbeh G, Katzir L, Vasiliauskas E, Bahar R, Otley A, Mack D, Evans J, Rosh J, Hemker MO, Leleiko N, Crandall W, Langton C, Landers C, Taylor KD, Targan SR, Rotter JI, Markowitz J, Hyams J. 2008. Increased immune reactivity predicts aggressive complicating Crohn’s disease in children. Western Regional Pediatric IBD Research Alliance; Pediatric IBD Collaborative Research Group; Wisconsin Pediatric IBD Alliance.  Clin Gastroenterol Hepatol. Vol. 6, no. 10. (October): 1105-1111.
• Saeed SA, Crandall WV. 2008. Managing Crohn disease in children and adolescents : focus on tumor necrosis factor antagonists. Review.  Pediatr Drugs. Vol. 10, no. 1. (July): 31-38.
• Punati J, Markowitz J, Lerer T, Hyams J, Kugathasan S, Griffiths A, Otley A, Rosh J, Pfefferkorn M, Mack D, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Mezoff A, Leleiko N, Keljo D, Crandall W. 2008. Effect of early immunomodulator use in moderate to severe pediatric Crohn’s disease. Pediatric IBD Collaborative Research Group.  Inflamm Bowel Dis. Vol. 14, no. 7. (July): 949-954.
• Nwomeh B, Crandall WV. 2008. Radiologic Evaluation of Pediatric Inflammatory Bowel Disease. In Pediatric Inflammatory Bowel Disease. Edited by Mamula, et al. New York: Springer Science+ Business Media, LLC.
• Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G,Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R, REACH Study Group. 2007. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.  Gastroenterology. Vol. 132, no. 3. (January): 863-873.
• Crandall WV, Halterman TE, Mackner LM. 2007. Anxiety and pain symptoms in children with inflammatory bowel disease and functional gastrointestinal disorders undergoing colonoscopy.  J of Pediatr Gastro Nutr. Vol. 44, no. 1. (January): 63-67.
• Mackner LM, Crandall WV. 2007. Psychological Aspects of IBD in Children and Adolescents. In Pediatric Inflammatory Bowel Disease. Edited by Mamula, et al. New York: Springer Science + Business Media, LLC.
• Kugathasan S, Nebel J, Skelton JA, Markowitz J, Keljo D, Rosh J, LeLeiko N, Mack D, Griffiths A, Bousvaros A, Evans J, Mezoff A, Moyer S, Oliva-Hemker M, Otley A, Pfefferkorn M, Crandall W, Wyllie R, Hyams J, Wisconsin Pediatric Inflammatory Bowel Disease. 2007. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts.  Journal of Pediatrics. Vol. 151, no. 5. (January): 523-527.
• Mackner LM, Crandall WV. 2007. Psychological factors affecting pediatric inflammatory bowel disease.  Current Opinion in Pediatrics. Vol. 19, no. 5. (January): 548-552.
• Mackner LM, Crandall WV. 2006. Brief Report: Psychosocial Adjustment in Adolescents with Inflammatory Bowel Disease.  J Pediatr Psychology. Vol. 31, no. 3. (April): 281-285.
• Mackner LM, Crandall WV, Szigethy E M. 2006. Psychosocial Functioning in Pediatric Inflammatory Bowel Disease.  Inflamm Bowel Dis. Vol. 12, no. 3. (March): 239-244.
• Sharrett MK, Russo JM, Crandall WV. 2006.
• Mackner LM, Crandall WV. 2005. Oral Medication Adherence in Pediatric Inflammatory Bowel Disease.  Inflamm Bowel Dis. Vol. 11, no. 11. (November): 1006-1012.
• Markowitz J, Markowitz J, Bousvaros A, Crandall W. 2005. Workshop Report: Prevention of Post-Operative Recurrence in Crohn's Disease.  J Pediatr Gastroenterol Nutr. Vol. 41, no. 2. (August): 145-151.
• Mackner LM, Crandall WV. 2005. Long-term Psychosocial Outcomes Reported by Children and Adolescents with Inflammatory Bowel Disease.  Am J Gastroenterol. Vol. 100, no. 6. (June): 1386-1392.
• Stark LJ, Hommel KA, Mackner LM, Janicke DM, Davis AM, Pferrerkorn M, Crandall W, Heubi J. 2005. Randomized Trial Comparing Two Methods of Increasing Dietary Calcium Intake in Children with Inflammatory Bowel Diseases.  J Pediatr Gastroenterol Nutr. Vol. 40, no. 4. (April): 501-507.
• Crandall WV, Barnard J, Cohen M, Coletti R, Ferry G, Harnsberger J, Hart M, Hayes J, Rosenthal P, Sherman P, Smith L. 2005. NASPGHAN Workforce Survey.  J Pediatr Gastroenterol Nutr. Vol. 40, no. 4. (April): 397-405.
• Moulton DE, Crandall WV, Lakhani R, Lowe ME. 2004. Expression of a Novel Cadherin in the Mouse and Human Intestine.  Pediatr Res. Vol. 55, no. 6. (June): 927-934.
• Mackner LM, Sisson DP, Crandall WV. 2004. Review: Psychosocial Issues in Pediatric Inflammatory Bowel Disease.  J Pediatr Psychology. Vol. 29, no. 4. (June): 243-257.
• Erdman SH, Crandall WV. 2003.
• Mackner LM, Crandall WV. 2003. Celiac Disease. In Encyclopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumber Academic/Plenum.
• Crandall WV, Mackner LM. 2003. Infusion Reactions to Infliximab in Children and Adolescents: Frequency, Outcome, and a Predictive Model.  Alim Phar Ther. Vol. 17, no. January: 75-84.
• Mackner LM, Crandall WV. 2003. Diarrhea. In Encyclopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumer Academic/Plenum.
• Mackner LM, Crandall WV. 2003. Gastroesophageal Reflux Disease. In Encyclopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C. New York: Klumer Academic/Plenum.
• Mackner LM, Crandall WV. 2003. Peptic Ulcer Disease. In Encyclopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumer Academic/Plenum.
• Mackner LM, Crandall WV. 2003. Hirschprung's Disease. In Encyclopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumer Academic/Plenum.
• Mackner LM, Crandall WV. 2003. Functional Dyspepsia. In Encydlopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumer Academic/Plenum.
• Mackner LM, Crandall WV. 2003. Irritable Bowel Syndrome. In Encyclopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumer Academic/Plenum.
• Mackner LM, Crandall WV. 2003. Gastrointestinal Disorders. In Encycolopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumer Academic/Plenum.
• Mackner LM, Crandall WV. 2003. Inflammatory Bowel Disease. In Encyclopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumer Academic/Plenum.
• Mackner LM, Crandall WV. 2003. Food Allergy. In Encyclopedia of Pediatric and Child Psychology. Edited by Ollendick T, Schroeder C (eds). New York: Klumer Academic/Plenum.
• Crandall WV. 2002. Gastroenterology. In Adolescent Medicine Secrets. Edited by In Holland-Hall CM, Brown RT. Philadelphia: Hanley & Belfus.
• Crandall WV, Lowe ME. 2001. Colipase Residues Glu and Arg are Essential for Normal Lipase Mediated Fat Digestion in the Presence of Bile Salt Micelles.  J Biol Chem. Vol. 276, no. 16. (April): 12505-12512.
• Erdman SH, Crandall WV. 2001.
• Crandall WV, Langer JC. 1999. Primary Omental Torsion Presenting as Hip Pain and Limp.  J Pediatr Gastroenterol Nutr. Vol. 28, no. 1. (January): 95-96.
• Crandall WV, Norlin C, Bulock EA, Shearrow ME, Tani LY, Orsmond GS, Shaddy RE. 1996. Etiology and Outcome of Outpatient Fevers in Pediatric Heart Transplant Patients.  Clin Pediatr. Vol. 35, no. 9. (September): 437-442.

• Listed, Best Doctors in America